What do you remember about this year’s big oncology coding changes? Find out. This year has seen a lot of changes in the field of oncology coding. As the field of medicine advances, so too does the way you document it. Here are three questions based on the biggest oncology coding stories from the last twelve months. Answer them correctly, and you’ll step confidently into 2022. Question 1: On Jan. 1, 2021, CPT® introduced a new core needle lung biopsy code. What was it, why was it introduced, and what are the correct — and incorrect ways — to report multiple biopsies at the same session using the code? Question 2: In October, ICD-10-CM introduced a new code for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). What was the code, what are the ICD-10-CM and guidelines accompanying it, and what other ICD-10-CM codes should you use and not use along with it? Question 3: CPT® 2022 introduced two new oncology-based molecular ribonucleic acid (mRNA) tests. How does this breakthrough testing work, and what were the codes for the two new tests? Think you know the answers? Click here and find out!